Kidney Disease Spectrum (renal Cancer Progression) Tissue Array, 80 Cases/80 Cores|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173353

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Kidney Disease Spectrum (renal Cancer Progression) Tissue Array, 80 Cases/80 Cores)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年05月16日 20時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Human, Kidney Disease Spectrum, Renal Cancer Progression, Tissue Array
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年05月16日 20時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Human, Kidney Disease Spectrum, Renal Cancer Progression, Tissue Array

文献数: 0

説明文
法規制等
保存条件 室温,暗所保存 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド/組織アレイの仕様変更につきまして

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Kidney disease spectrum (renal carcinoma progression) tissue microarray, containing 26 cases of clear cell carcinoma, 10 transitional cell carcinoma, 8 papillary carcinoma, 7 squamous cell carcinoma, 2 collecting duct carcinoma, 2 undifferentiated carcinoma, 5 each of metastatic carcinoma, inflammation, adjacent tissue, adjacent normal tissue and normal tissue, single core per case
Cores: 80
組織アレイ
Cases: 80
Layout: 10 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 59 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A2 2 M 52 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A3 3 M 36 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A4 4 F 50 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A5 5 M 67 Kidney Clear cell carcinoma (serosity and blood) III T3N0M0 Malignant
A6 6 M 50 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A7 7 F 73 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A8 8 M 45 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A9 9 M 54 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
A10 10 F 64 Kidney Clear cell carcinoma 1 II T2N0M0 Malignant
B1 11 M 62 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
B2 12 F 71 Kidney Clear cell carcinoma 1 II T2N0M0 Malignant
B3 13 M 60 Kidney Clear cell carcinoma 1 II T2N0M0 Malignant
B4 14 M 66 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
B5 15 M 51 Kidney Clear cell carcinoma (sparse) 1 I T1N0M0 Malignant
B6 16 M 74 Kidney Clear cell carcinoma 2 II T2N0M0 Malignant
B7 17 M 47 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
B8 18 M 56 Kidney Clear cell carcinoma 2 I T1N0M0 Malignant
B9 19 M 67 Kidney Clear cell carcinoma 2 II T2N0M0 Malignant
B10 20 M 73 Kidney Clear cell carcinoma 2 I T1N0M0 Malignant
C1 21 M 54 Kidney Clear cell carcinoma 1–2 I T1N0M0 Malignant
C2 22 F 64 Kidney Clear cell carcinoma 2 I T1N0M0 Malignant
C3 23 M 46 Kidney Clear cell carcinoma 2 I T1N0M0 Malignant
C4 24 M 78 Kidney Clear cell carcinoma 2 III T3N0M0 Malignant
C5 25 M 54 Kidney Clear cell carcinoma 1 I T1N0M0 Malignant
C6 26 M 65 Kidney Clear cell carcinoma 2 III T3N0M0 Malignant
C7 27 F 75 Kidney Transitional cell carcinoma 1–2 I T1N0M0 Malignant
C8 28 M 80 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
C9 29 F 75 Kidney Transitional cell carcinoma 2 II T2N0M0 Malignant
C10 30 M 74 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
D1 31 M 68 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
D2 32 M 62 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
D3 33 M 47 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
D4 34 M 71 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
D5 35 M 60 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
D6 36 M 44 Kidney Transitional cell carcinoma 2 I T1N0M0 Malignant
D7 37 M 40 Kidney Papillary renal cell carcinoma I T1N0M0 Malignant
D8 38 M 48 Kidney Papillary renal cell carcinoma I T1N0M0 Malignant
D9 39 M 18 Kidney Papillary renal cell carcinoma I T1N0M0 Malignant
D10 40 F 39 Kidney Papillary renal cell carcinoma I T1N0M0 Malignant
E1 41 M 50 Kidney Papillary renal cell carcinoma I T1N0M0 Malignant
E2 42 M 46 Kidney Papillary renal cell carcinoma I T1N0M0 Malignant
E3 43 M 30 Kidney Papillary renal cell carcinoma IV T1N0M1 Malignant
E4 44 M 35 Kidney Papillary renal cell carcinoma III T1N1M0 Malignant
E5 45 F 51 Kidney Squamous cell carcinoma 1 II T2N0M0 Malignant
E6 46 M 59 Kidney Squamous cell carcinoma 1 II T2N0M0 Malignant
E7 47 M 63 Kidney Squamous cell carcinoma (fibrous tissue and blood vessel) I T1N0M0 Malignant
E8 48 M 54 Kidney Squamous cell carcinoma 1 I T1N0M0 Malignant
E9 49 F 57 Kidney Squamous cell carcinoma 2 III T3N0M0 Malignant
E10 50 M 53 Kidney Squamous cell carcinoma 2 I T1N0M0 Malignant
F1 51 M 67 Kidney Squamous cell carcinoma 1–2 I T1N0M0 Malignant
F2 52 M 35 Kidney Collecting duct carcinoma III T3N0M0 Malignant
F3 53 M 69 Kidney Collecting duct carcinoma II T2N0M0 Malignant
F4 54 M 36 Kidney Undifferentiated carcinoma III T3N0M0 Malignant
F5 55 F 37 Kidney Undifferentiated carcinoma I T1N0M0 Malignant
F6 56 M 58 Pelvic cavity Metastatic chromophobe carcinoma Metastasis
F7 57 M 43 Retroperitoneum Metastatic clear cell carcinoma Metastasis
F8 58 F 45 Retroperitoneum Metastatic clear cell carcinoma Metastasis
F9 59 M 71 Right adrenal gland Metastatic clear cell carcinoma Metastasis
F10 60 M 60 Adrenal gland Metastatic clear cell carcinoma Metastasis
G1 61 F 52 Kidney Chronic pyelonephritis Inflammation
G2 62 F 52 Kidney Acute pyelonephritis Inflammation
G3 63 F 63 Kidney Interstitial nephritis Inflammation
G4 64 M 55 Kidney Interstitial nephritis Inflammation
G5 65 F 52 Kidney Interstitial nephritis Inflammation
G6 66 M 49 Kidney Cancer adjacent tissue (interstitial nephritis) Adjacent
G7 67 M 39 Kidney Cancer adjacent tissue Adjacent
G8 68 M 52 Kidney Cancer adjacent tissue Adjacent
G9 69 M 65 Kidney Cancer adjacent tissue Adjacent
G10 70 M 60 Kidney Cancer adjacent tissue (interstitial nephritis) Adjacent
H1 71 M 23 Kidney Cancer adjacent normal renal tissue NAT
H2 72 M 52 Kidney Cancer adjacent normal renal tissue NAT
H3 73 M 59 Kidney Cancer adjacent normal renal tissue NAT
H4 74 M 65 Kidney Cancer adjacent normal renal tissue NAT
H5 75 F 49 Kidney Cancer adjacent normal renal tissue NAT
H6 76 F 14 Kidney Normal renal tissue Normal
H7 77 M 40 Kidney Normal renal tissue Normal
H8 78 F 38 Kidney Normal renal tissue Normal
H9 79 M 47 Kidney Normal renal tissue Normal
H10 80 M 22 Kidney Normal renal tissue Normal
M 58 Skin Malignant melanoma (tissue marker) Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。